Lewis T. Williams

Insider Reports History

Location
Newark, CA
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Lewis T. "Rusty" Williams
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lewis T. Williams:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arcellx, Inc. Director Common Stock 2,095,114 $115,792,551 $55.27 08 Feb 2022 Indirect
Protagonist Therapeutics, Inc Director Common Stock 7,825 $683,433 $87.34 02 Jan 2026 Direct
Neoleukin Therapeutics, Inc. Director Stock Option (Right to Buy) 25,000 11 May 2021 Direct
Protagonist Therapeutics, Inc Director Stock Option (right to buy) 3,762 02 Jan 2026 Direct
Arcellx, Inc. Director Series B-1 Preferred Stock 0 08 Feb 2022 Indirect
Arcellx, Inc. Director Series B-2 Preferred Stock 0 08 Feb 2022 Indirect

Insider Reports Filed by Lewis T. Williams

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PTGX Protagonist Therapeutics, Inc 02 Jan 2026 2 $0 4 Director 06 Jan 2026, 19:40
PTGX Protagonist Therapeutics, Inc 02 Jan 2025 2 $0 4 Director 06 Jan 2025, 18:09
PTGX Protagonist Therapeutics, Inc 02 Jan 2024 1 $0 4 Director 04 Jan 2024, 20:14
PTGX Protagonist Therapeutics, Inc 16 Jan 2023 1 $0 4 Director 18 Jan 2023, 19:10
PTGX Protagonist Therapeutics, Inc 26 May 2022 1 $0 4 Director 27 May 2022, 16:01
ACLX Arcellx, Inc. 08 Feb 2022 3 $0 4 Director 09 Feb 2022, 16:54
ACLX Arcellx, Inc. 03 Feb 2022 0 $0 3 Director 03 Feb 2022, 16:26
PTGX Protagonist Therapeutics, Inc 27 May 2021 1 $0 4 Director 28 May 2021, 19:06
NGNE Neoleukin Therapeutics, Inc. 11 May 2021 1 $0 4 Director 13 May 2021, 17:39